▶주메뉴 바로가기
▶본문 바로가기
[THE INVESTOR] Nature Republic, a Korean cosmetics firm, said on June 4 it has opened its first outlet in Saudi Arabia as it moves to its expand presence in overseas markets. Nature Republic sai...
[THE INVESTOR] Korea’s major biopharmaceutical companies have headed to Boston this week to take part in the 2018 Bio International Convention, with aims to promote their technologies to interested ...
[THE INVESTOR] The financial regulator has wrapped up its review of a regulatory probe into whether Samsung BioLogics violated accounting rules, officials said on June 1. Details of the revie...
[THE INVESTOR] LG Chem said on May 30 that it has launched Etanercept BS [MA], its biosimilar referencing Amgen’s rheumatoid arthritis drug Enbrel in Japan. By introducing the first Enbrel biosimil...
[THE INVESTOR] Celltrion said on May 30 that it has resubmitted its application to gain marketing authorization from the US Food and Drug Administration for Truxima, its copy version of Roche’s blo...
[THE INVESTOR] Medytox has sent out a pilot batch of its liquid-type botulinum toxin Innotox to its US partner Allergan to initiate the long-awaited phase 3 clinical trials of the drug candidate tha...
[THE INVESTOR] Wrapping up a month-long review, the country’s top financial regulator is poised to hold the final session of Samsung BioLogics ' alleged accounting irregularities on May 31 before ...
[THE INVESTOR] Samsung BioLogics CEO Kim Tae-han attended the second round of meeting with financial authorities on May 25 to make another attempt to allay suspicions of exaggerating the value of i...
[THE INVESTOR] Celltrion Healthcare , which handles Celltrion’s overseas business, has pulled itself out of the red by reporting a net profit of 60.5 billion won (US$56.06 million) for the first qu...
[THE INVESTOR] Feelux said on May 24 that it will establish a subsidiary in the US in a bid to accelerate the development of immunotherapy for cancer. The board of of directors has decided to make...
[THE INVESTOR] Samsung BioLogics said on May 24 that the production of a third monoclonal antibody drug substance has been approved by the US Food and Drug Administration for its second plant. Wit...
[THE INVESTOR] JW Holdings said on May 23 it has signed export deals with Brazil-based Sif Participacoe and India’s Alniche Lifescience to venture into emerging markets. The Korean company will sup...
[THE INVESTOR] Over the past three weeks, Samsung BioLogics has been facing drastic changes inside and out after the country’s financial authorities alleged that it had intentionally misapplied an a...
[THE INVESTOR] Korean drug company GC Pharma set up vaccine manufacturer Curevo in the United States toward the end of last year, industry sources reported for the first time on May 21. The Seat...
[THE INVESTOR] Samsung BioLogics said on May 18 that Biogen Therapeutics has confirmed that it will increase its stake in their joint venture Samsung Bioepis up to nearly 50 percent in a move that ...
L-Tree applies biometric technology to blockchain
Market Kurly operator secures W67b investment
Samsung's cooktops get high scores from U.S. Consumer Report
Two Samsung Group affiliates sell stake in Samsung C&T
KT ties up with firm behind Apple’s Siri for car infotainment systems
Samsung unveils triple-lens smartphone Galaxy A7
Parliament passes bill easing regulations on internet-only banks
Hanon Systems to acquire Magna’s fluid pressure and controls biz
September 26, 2018
